Clinical pharmacist‐led costs optimization in ischaemic stroke care: A diagnosis‐related groups‐based intervention study

This study aimed to evaluate the impact of clinical pharmacists' intervention on drug cost optimization for ischaemic stroke inpatients under the diagnosis-related groups (DRGs) payment model. This study collected hospitalization data of patients with ischaemic stroke in the BR23 disease group...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	British journal of clinical pharmacology Ročník 91; číslo 12; s. 3529
Hlavní autoři:	Li, Yun, Li, Xianlin, Guo, Haitao, Zhang, Jin, Zheng, Xiaojun
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 21.08.2025
Témata:	Aged Aged, 80 and over Diagnosis-Related Groups - economics Drug Costs - statistics & numerical data Drug-Related Side Effects and Adverse Reactions - economics Drug-Related Side Effects and Adverse Reactions - epidemiology Drug-Related Side Effects and Adverse Reactions - prevention & control Female Hospitalization - economics Hospitalization - statistics & numerical data Humans Ischemic Stroke - drug therapy Ischemic Stroke - economics Length of Stay - economics Length of Stay - statistics & numerical data Male Middle Aged Pharmacists - economics Pharmacists - organization & administration Pharmacy Service, Hospital - economics Pharmacy Service, Hospital - organization & administration Professional Role cost control clinical pathways pharmacists neurology diagnosis‐related groups
ISSN:	0306-5251, 1365-2125, 1365-2125
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!